Skip to main content

WHO reviewing policy after rejecting emergency use of Canadian-made COVID-19 vaccine

Share
OTTAWA -

The World Health Organization says it is reviewing its policies after opting not to accept a made-in-Canada COVID-19 vaccine for emergency use.

Health Canada authorized Medicago's two-dose Covifenz vaccine in February for adults 18 to 64.

Medicago says WHO did "not accept" its application because it has a strict policy not to engage with companies that promote tobacco, and Philip Morris owns about one-fifth of the company.

WHO says it is now exploring different policy options for health products linked to the tobacco industry.

The federal government signed an agreement with Medicago in 2020 to buy 20 million doses once the vaccine was approved by Health Canada, with the option to purchase 56 million more.

The government's ability to donate those doses to countries in need could be seriously impeded without WHO emergency approval.

CTVNews.ca Top Stories

Opinion

Opinion I just don't get Taylor Swift

It's one thing to say you like Taylor Swift and her music, but don't blame CNN's AJ Willingham's when she says she just 'doesn't get' the global phenomenon.

Local Spotlight

DonAir force takes over at Oilers playoff games

As if a 4-0 Edmonton Oilers lead in Game 1 of their playoff series with the Los Angeles Kings wasn't good enough, what was announced at Rogers Place during the next TV timeout nearly blew the roof off the downtown arena.

Stay Connected